ondansetron (orally disintegrating tablet)

ondansetron · Par Pharmaceutical, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ondansetron (orally disintegrating tablet), covering 2008-04-11 to 2008-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions [Phase 1]